Journal • Combination therapy
|
ABL1 (ABL proto-oncogene 1) • BCR (BCR Activator Of RhoGEF And GTPase) • CCND1 (Cyclin D1) • CDK4 (Cyclin-dependent kinase 4) • CDK6 (Cyclin-dependent kinase 6) • SQSTM1 (Sequestosome 1) • IR (Insulin receptor) • BECN1 (Beclin 1)
|
CCND1 expression • CDK6 expression
|
dasatinib • BMS-754807